Key result
Prazosin reduces closed-loop coronary flow autoregulation gain ~41%, indicating alpha-1 adrenoceptor modulation.
Why the study?
Does alpha-adrenergic blockade alter coronary autoregulation in anesthetized dogs?
Does alpha-adrenergic blockade alter coronary autoregulation in anesthetized dogs?
An alpha 1-adrenoceptor mediated coronary constriction modulates coronary autoregulation in dogs.
Alpha-1 blockade attenuates coronary autoregulation in this canine model; leaves open translation to human physiology or therapy.
In alpha-chloralose-anesthetized, open-chest dogs, left coronary blood flow and oxygen extraction were measured at perfusion pressures from 25 to 175 mmHg. Pressure-flow relationships were obtained before and after alpha-blockade with prazosin or alpha 2-blockade with yohimbine in the presence of beta-blockade with propranolol. The efficiency of flow autoregulation with increments in pressure was calculated as the closed-loop gain and as the slope of flow to pressure. In all animals the highest gain and the lowest slope were seen when pressure increased from 75 to 125 mmHg. In the prazosin group before alpha-blockade the gain with this pressure increase was 0.76 +/- 0.05, whereas in the yohimbine group before alpha-blockade this gain was 0.75 +/- 0.03. Prazosin reduced the gain within the pressure range of 75-125 mmHg by 41%, and this reduction was statistically significant (P less than 0.05). Prazosin also significantly increased the flow to pressure slope within this range. In addition, at all pressures greater than or equal to 50 mmHg, the level of coronary flow was significantly increased by prazosin. The increase in flow and the reduction in autoregulatory efficiency with prazosin were not attributable to an increase in myocardial oxygen consumption. Yohimbine had no effects on the level of coronary flow or on the autoregulatory efficiency. These data indicate that an alpha 1-adrenoceptor mediated coronary constriction modulates coronary autoregulation.
No takes yet. Share an insight, caveat, or question.
Jones et al. (1987) studied this question. Prazosin or yohimbine vs. Before alpha-blockade was evaluated on Efficiency of flow autoregulation (closed-loop gain) with pressure increase from 75 to 125 mmHg (41% reduction, p=<0.05). Prazosin significantly reduced the closed-loop gain of coronary flow autoregulation by 41% (P<0.05), whereas yohimbine had no effect, indicating alpha 1-adrenoceptor modulation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: